FDA Import Refusal 799-1366861-5/10003/1 — SHREE PHARMA
The FDA refused shipment 799-1366861-5/10003/1 from SHREE PHARMA (India) on Jan 9, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Jan 9, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75